Verastem (VSTM) Inventory Average (2018 - 2026)

Verastem (VSTM) posted quarterly Inventory Average of $2.1 million for Q1 2026, up 13.59% quarter-over-quarter from $1.8 million in Q4 2025.

Analysis

Verastem (VSTM) Inventory Average (2018 - 2026) Analysis & Trends

Verastem's Inventory Average history runs 5 years deep, the most recent figure standing at $2.1 million for Q1 2026.

In Q1 2026, Inventory Average changed N/A year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (changed N/A YoY), while the FY2019 annual figure was $1.7 million, changed N/A from the prior year.
Inventory Average for Q1 2026 stood at $2.1 million, up from $1.8 million in the prior quarter.
The five-year high for Inventory Average was $2.1 million in Q1 2026, with the low at $1.5 million in Q3 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	138.51 Bn	130.66 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	85.24 Bn	77.25 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	63.46 Bn	58.28 Bn	1.37 Bn	-
4	Moderna	57.89 Bn	52.75 Bn	52.00 Mn	213.00 Mn
5	Revolution Medicines	44.02 Bn	44.02 Bn	-	-
6	BeOne Medicines	39.95 Bn	34.85 Bn	1.53 Bn	707.10 Mn
7	Alnylam Pharmaceuticals	35.49 Bn	32.19 Bn	992.69 Mn	90.57 Mn
8	Royalty Pharma	28.43 Bn	27.59 Bn	-	-
9	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	137.65 Mn
10	Verastem	815.95 Mn	679.59 Mn	36.32 Mn	2.34 Mn

Historic Data

Download Data